The Bright Side of the Road: FDA Decision on MDMA Leaves Psychedelic Therapy Down, Far From Out

By Hillary Campbell & Whitt Steineker on August 26, 2024 Posted in Federal Agencies, Psychedelics We at Budding Trends have been optimistic, and then cautiously optimistic, that the legalization of psychedelics was close. This month, however, the U.S. Food and Drug Administration dealt a blow to our predictions. FDA decided not to approve Lykos Therapeutics, Inc.’s MDMA-assisted PTSD therapy at this time. Instead, FDA asked Lykos to further […]